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Abstract. 
 
Urothelium synthesizes a group of inte-
gral membrane proteins called uroplakins, which form
two-dimensional crystals (urothelial plaques) covering
 
.
 
90% of the apical urothelial surface. We show that the
ablation of the mouse uroplakin III (UPIII) gene leads
to overexpression, defective glycosylation, and abnor-
mal targeting of uroplakin Ib, the presumed partner of
UPIII. The UPIII-depleted urothelium features small
plaques, becomes leaky, and has enlarged ureteral ori-
ﬁces resulting in the back ﬂow of urine, hydronephrosis,
and altered renal function indicators. Thus, UPIII is an
integral subunit of the urothelial plaque and contrib-
utes to the permeability barrier function of the urothe-
lium, and UPIII deﬁciency can lead to global anomalies
in the urinary tract. The ablation of a single urothelial-
 
speciﬁc gene can therefore cause primary vesicoureteral
 
reﬂux (VUR), a hereditary disease affecting 
 
z
 
1% of
pregnancies and representing a leading cause of renal
failure in infants. The fact that VUR caused by UPIII
deletion seems distinct from that caused by the deletion
of angiotensin receptor II gene suggests the existence
of VUR subtypes. Mutations in multiple gene, including
some that are urothelial speciﬁc, may therefore cause
different subtypes of primary reﬂux. Studies of VUR in
animal models caused by well-deﬁned genetic defects
should lead to improved molecular classiﬁcation, pre-
natal diagnosis, and therapy of this important heredi-
tary problem.
Key words: urothelium • permeability • knockout
mice • vesicoureteral reﬂux • hydronephrosis
 
Introduction
 
Urothelium, also known as transitional epithelium in older
literature, lines almost the entire urinary tract including the
renal pelvis, ureter, bladder, and proximal urethra (Hicks,
1975). Over 90% of the urothelial apical surface of the
superficial umbrella cells is covered by rigid-appearing
plaques (also known as asymmetric unit membranes) that
are 0.2–0.5 
 
m
 
m in diameter (Porter and Bonneville, 1963;
Hicks, 1965; Koss, 1969; Staehelin et al., 1972; Kachar et al.,
1999). These plaques consist of two-dimensional crystalline
arrays of hexagonally arranged 16-nm protein particles
(Hicks and Ketterer, 1969; Vergara et al., 1969; Brisson and
Wade, 1983; Walz et al., 1995; Kachar et al., 1999) that are
composed of uroplakins—a group of integral membrane
proteins synthesized by mammalian urothelia as their ma-
jor differentiation products (Wu et al., 1990, 1994; Yu et al.,
1990, Sun et al., 1999). It has been suggested that these
urothelial plaques: (a) stabilize the apical surface, thus pre-
venting urothelial rupture during bladder distention (Stae-
helin et al., 1972); (b) regulate the apical surface area by
their reversible retrieval from, and insertion into, the apical
surface (Minsky and Chlapowski, 1978; Lewis and de
Moura, 1982); and (c) contribute to the remarkable perme-
ability barrier function of the urothelium (Hicks, 1975;
Chang et al., 1994; Negrete et al., 1996). Thus far, four
 
uroplakins (UP)
 
1
 
 [i.e., UPIa (27 kD), UPIb (28 kD), UPII
(15 kD), and UPIII (47 kD], have been identified (Wu and
Sun, 1993, Lin et al., 1994, Yu et al., 1994). The precise bio-
logical functions of the uroplakins, and the abnormalities
that may be caused by uroplakin defects, are unknown.
Primary vesicoureteral reflux (VUR; OMIM, 1999), the
retrograde flow of urine from the bladder into ureters and
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kidneys, is hereditary as there is a 30–50-fold increased in-
cidence of VUR in first degree relatives of such patients
(Noe et al., 1992; Belman, 1997; Atala and Keating, 1998;
Dillon and Goonasekera, 1998). VUR affects 0.5–1% of
the population and is, therefore, one of the more common
congenital abnormalities (Smellie and Normand, 1979;
King, 1992; Becker and Avner, 1995; Belman, 1997; Atala
and Keating, 1998; Dillon and Goonasekera, 1998; Hir-
aoka et al., 1999; Horowitz et al., 1999). Infants or young
children with VUR are highly susceptible to urinary tract
infection. Reflux of infected urine into the kidneys can
cause acute pyelonephritis and subsequent renal scarring,
hypertension, and end-stage renal disease. Although VUR
is the most common cause of renal failure in children, and
an important cause in adults (Kincaid-Smith et al., 1984;
Eccles et al., 1996), the genetic basis for VUR has not yet
been clearly defined.
In this paper, we show that germline deletion of mouse
uroplakin III gene resulted in the selective perturbation of
its presumed partner, UPIb, and in the formation of a
grossly abnormal urothelium devoid of a typical umbrella
cell layer. The apical urothelial surface was covered with
unusually small urothelial plaques interspersed by greatly
expanded (particle-free) “hinge” areas, and the urothe-
lium became leaky. Moreover, the mice had greatly en-
larged ureteral orifices leading to vesicoureteral reflux, hy-
dronephrosis, and altered renal function indicators. These
results suggest that uroplakin III is an integral subunit of
urothelial plaques that play a key role in urothelial struc-
ture and function, that urothelial defects can have global
effects on the entire urinary system including the kidneys,
and that mutations in a panel of urothelial-specific genes
may play a role in human VUR.
 
Materials and Methods
 
Production of the UPIII Knockout Mice
 
Genomic clones of mouse UPIII gene were isolated from a 129/Ola mouse
P1 genomic library (Genome Systems). The targeting vector, designed to
delete exons 1–3 of the UPIII gene, contained four portions: a 5-kb AvaI
mouse UPIII fragment upstream of exon 1, the neomycin-resistance gene
driven by the phosphoglycerate kinase (PGK) promoter in the opposite di-
rection, a 3-kb BamHI mouse UPIII genomic fragment downstream of
exon 3, and the thymidine kinase gene of herpes simplex virus driven by
the PGK promoter (Joyner, 1993; Ramirez-Solis et al., 1993). The XhoI-
linearized vector was electroporated into 129/SvEv embryonic stem cell
line W4, and the Neo-positive and TK-negative transformants were se-
lected using G418 (240 
 
m
 
g/ml) and gancyclovir (2 
 
m
 
M). 2 of 150 embryonic
stem (ES) cell colonies were found to harbor the correct homologous re-
combination events as determined by Southern blotting using the “Probe”
and by long-range PCR using primers LP1 and LP2 (Fig. 1 a, below). The
confirmed ES cell clones were amplified and aggregated with eight cell-
stage embryos of Swiss Webster mice, and implanted into pseudopregnant
females. Five chimeric mice from two ES cell lines were germline-transmit-
ting, and were bred with SW mice to yield hybrid homozygotes, or mated
with 129/SvEv mice to yield inbred 129/SvEv UPIII–knockout mice.
 
RNA and Protein Analyses
 
Total RNA was isolated using RNAgents System (Promega), separated
on a 1% agarose/formaldehyde gel, and transferred to a Hybond-N mem-
brane (Amersham Pharmacia Biotech). For Western blot analysis, total
(SDS-solubilized) urothelial proteins from the equivalent of a quarter of a
mouse bladder were separated on a 17% SDS-polyacrylamide gel, and
transferred onto an MSI-nitrocellulose membrane (Fisher Scientific). The
membrane was treated with 5% nonfat dry milk in PBS, and incubated
 
with an antibody. For immunohistochemistry, mouse tissues were fixed in
4% paraformaldehyde in PBS, paraffin-embedded, cut into 5-
 
m
 
m sections,
and immunostained using the peroxidase-antiperoxidase technique. Anti-
bodies used in this study included: AE1 and AE3 mouse monoclonal anti-
bodies to keratins (Tseng et al., 1982; Sun et al., 1984), rabbit antisera
against synthetic peptides of individual uroplakins (Wu and Sun, 1993; Wu
et al., 1994), and a mouse monoclonal antibody against uroplakin III
(Riedel et al., 2000).
 
Electron Microscopy and Quick-Freeze/Deep Etch
 
For transmission electron microscopy, mouse bladder was cut into small
pieces (
 
,
 
1 mm
 
2
 
), fixed with 2.5% glutaraldehyde in 0.1 M sodium caco-
dylate buffer, pH 7.4, post-fixed with 2% (wt/vol) osmium tetroxide, and em-
bedded in Epon 812 (Polysciences, Inc.). For scanning EM, a bladder was
bisected, fixed as above, and critical-point dried. For quick-freeze/deep
etch, a fixed mouse bladder was cut into halves, rinsed with distilled water,
and frozen to liquid nitrogen temperature using a Life Cell CF-100 freez-
ing apparatus (Kachar et al., 1999; Liang et al., 1999).
 
Determination of the Micturition Pattern
 
The urination pattern was determined using a filter paper assay. 3-mo-old
wild-type and UPIII-knockout mice were housed in a 12 h:12 h day/night
cycled, germ-free animal facility. Mice were placed singly in a special cage
fitted with a fine-meshed bottom, thus allowing the urine to land on a
piece of filter paper, which could be changed periodically. Calibration
studies established that the surface areas covered by the mouse urine,
which was strongly fluorescent and thus could be easily visualized under a
UV light, provided an accurate measurement of the urine volume (with a
linear range of up to 
 
z
 
500 
 
m
 
l).
 
Blood Urea Nitrogen and Serum Creatinine
 
Blood samples from mice (3-mo old) were drawn from the orbital sinus.
Sera were prepared and the BUN and creatinine concentrations were
measured by Antech Diagnostics.
 
Determination of Reflux Pressure and Dye Penetration
 
Mice (2–3-mo old) were anaesthetized by i.m. injection of a mixture of xy-
lazine (10 mg/kg; Fort Dodge Animal Health) and ketamine (200 mg/kg;
Bayer). The abdomens of the mice were surgically opened under a stereo-
microscope to expose the urinary bladder. A 25-gauge butterfly needle
(Fisher Scientific) was connected to a 5-ml syringe filled with a 0.1%
rhodamine (Sigma-Aldrich) or an Indian Ink solution (10% vol/vol) in
0.9% NaCl, and was inserted into the bladder. The syringe was gradually
raised at the rate of 
 
z
 
1 cm per min, and the hydrostatic pressure (cm-
H
 
2
 
O) at which urination or reflux occurred was recorded. If reflux did not
occur even after urination, the urethral outlet was sealed by suture or by
applying a drop of glue (Magic Glue). The experiment was then repeated
to determine the pressure at which reflux occurred (at a pressure higher
than micturition pressure). If vesicoureteral reflux did not occur at 90 cm-
H
 
2
 
O, the experiment was discontinued and the “vesicoureteral reflux
pressure” was recorded as 90 cm-H
 
2
 
O. For voiding cystoureterograms, io-
thalamate meglumine (Mallinckradt Inc.) was infused into mouse bladder
through a PE10 urethra catheter (0.28 mm i.d., 0.61 mm o.d.), and the ani-
mals were x rayed while the pressure was raised progressively.
For dye-leakage assays, mice were anaesthetized using xylazine/ket-
amine and catheterized using a PE10 tube. After the bladder was emptied
by applying gentle pressure to the belly, 200 
 
m
 
l of 0.1% methylene blue
(Sigma-Aldrich) in 0.9% NaCl was instilled into the bladder (Fukui et al.,
1983). The solution was removed 20 min later, and the bladder was washed
with 3 ml of 0.9% NaCl solution. The bladder was extracted with 1 ml chlo-
roform at 50
 
8
 
C overnight, and the OD 660 nm of the solvent was measured.
 
Results
 
Generation of Uroplakin III–depleted Mice
 
To ablate the mouse UPIII gene, we designed a targeting
vector to delete its first three exons and to create a frame-
shift mutation in its remaining exons (Fig. 1 a). The linear-
ized vector was electroporated into W4 embryonic stem 
Hu et al. 
 
Uroplakin Ablation and Vesicoureteral Reflux
 
963
 
cells, and the neo- and gancyclovir-resistant cells were se-
lected. Two ES cell colonies (C1 and C2) harbored the de-
sired recombination events according to PCR and Southern
blot analysis (data not shown), and gave rise to germline-
transmitting chimeric mice. Five male chimeras (four C1
and one C2) carrying the mutated UPIII gene were crossed
with SW (or 129/SvEv) females to generate F1 heterozy-
gotes, which were then bred to produce the F2 hybrids, with
the mutated UPIII allele segregating in a Mendelian fashion
(Fig. 1, b and c). Since similar results were obtained from
the offspring of the two ES clones, six UPIII (
 
2
 
/
 
2
 
) breed-
ing pairs from C1 were used to produce homozygous F2
(
 
2
 
/
 
2
 
) mice. Two of the pairs yielded offspring that were
small and most of them died 10–14 d postnatally (see be-
low). The other four pairs produced UPIII (
 
2
 
/
 
2
 
) offspring
that showed consistent and well-defined urinary tract de-
fects; these animals, which grew and reproduced relatively
normally, were characterized in detail and reported here.
Figure 1. Ablation of upk3 gene affected the expression of other
uroplakins. (a) Alignment of the upk3 locus, the targeting vector
(V), and the mutated locus (KO). Solid boxes, exons; X, potential
crossover site; probe, a genomic probe; LP1 and 2, long-template
PCR primers; PCR1 and 2, PCR products characteristic of the wild-
type and KO alleles, respectively; Neo, neomycin-resistant gene;
TK, thymidine kinase of the herpes simplex virus; A, AvaI; B,
BamHI; E, EcoRI; T, TaqI; and X, Xhol. (b) Southern analysis of
the EcoRI-digested mouse genomic DNA with the P probe that
recognized 14- and 5-kb fragments from the wild-type and KO al-
lele, respectively. 1/1, wild type; 1/2, heterozygote; and 2/2, ho-
mozygote. (c) PCR analysis of the genomic DNA using a mixture of
two pairs of primers that generated a 300- and an 800-bp product
characteristic of the wild-type and KO allele, respectively.  (d)
Northern analysis. Total RNA samples (10 mg) were resolved elec-
trophoretically and probed with cDNA of mouse uroplakins Ia,
Ib, II, and III, and glyceraldehyde phosphate dehydrogenase
(GAPDH). Note the absence of UPIII message, and the z53 in-
crease in UPIb message in the 2/2 animal. (e) Ethidium bromide-
stained rRNA of the samples in d as a loading control. M in lane 7
denotes RNA size markers. (f) Immunoblot analyses of mouse
uroplakin proteins Ia (27 kD), Ib (28 kD), II (15 kD), and III (47
kD). Bovine total uroplakins (B) were included as a positive con-
trol. Note in the 2/2 mice the absence of UPIII, the roughly nor-
mal amounts of UPIa and UPII, and the absence of the major, slow-
est migrating UPIb species, possibly due to defective glycosylation.
Figure 2. UPIII-depleted urothelium lacked the umbrella cells
and was leaky. Normal (a, c, and e) and UPIII-depleted mouse
bladders (b, d, and f), all from 2–3-mo-old mice, were examined
using hematoxylin and eosin–stained paraffin sections (a and b),
or using toluidine blue-stained plastic thin sections (c and d). Ap-
pearance of methylene blue-stained wild-type (e) and UPIII-
knockout (f) mouse bladders. (g) Retention of methylene blue by
wild-type (n 5 7) and UPIII-depleted mouse (n 5 5) bladder
(P 5 0.019). The dye that was retained by the bladder was solubi-
lized with chloroform and read at 660 nm. Note the rugged lumi-
nal surface of the normal, superficial umbrella cells (arrows), and
the markedly different UPIII-depleted urothelium, which was
characterized by a smooth, apical cell surface (arrowheads), the
absence of an umbrella cell layer, and the leakiness/retention of
methylene blue. L, bladder lumen; M, mesenchyme; and U,
urothelium. Bars: 50 mm (a and b) and 25 mm (c and d). 
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Perturbed Uroplakin Expression and Grossly Abnormal 
Urothelial Apical Surface
 
The homozygous mice lacked UPIII message (Fig. 1 d,
lane 13) and protein (f, lane 16), thus confirming the abla-
tion of UPIII gene. The heterozygotes had a reduced
amount of UPIII, suggesting a gene dosage effect (Fig. 1 d,
lane 12, and f, lane 15). The mRNA level of UPIb, which
we previously suggested pairs with UPIII (Wu et al., 1995),
was elevated approximately fivefold (Fig. 1 d, lane 6),
while those of UPIa (lane 3) and UPII (lane 10) increased
only approximately twofold. On the protein level, while
the migration patterns of UPIa and II were normal (Fig. 1
f, lanes 4 and 12), UPIb was altered in that its major, high-
est molecular weight species was missing, suggesting in-
complete glycosylation (lane 8) (Yu et al., 1994). Taken to-
gether, these results clearly established the elimination of
UPIII in the homozygous (
 
2
 
/
 
2
 
) mice, and indicated that
UPIII ablation affected more the synthesis and processing
of UPIb, its presumed partner (Wu et al., 1995), than those
of UPIa and UPII (also see below).
 
While normal mouse urothelium was relatively thin, con-
sisting of three to four nuclear tiers with a characteristic, su-
perficial “umbrella” cell layer (Fig. 2, a and c), the UPIII-
depleted urothelium was almost twice as thick due to an
increase in nuclear tiers four to five, as well as a change of
the superficial squamous cells to become cuboidal or even
columnar (Fig. 2, b and d). We then examined the ultra-
structure of these altered superficial cells, which no longer
possessed a typical umbrella cell layer (Fig. 2, b and d), by
scanning and transmission electron microscopy, as well as
by the quick-freeze deep-etch technique (Figs. 3 and 4).
Normal umbrella cells could be as large as 150 
 
m
 
m in diame-
ter (Fig. 3, a and e), their cytoplasm was filled with
uroplakin-delivering fusiform vesicles (Fig. 4 a), and they
had a rugged apical surface due to the presence of numer-
ous plaques (Figs. 3, a and c, and 4 a) consisting of 16-nm
particles hexagonally arranged forming two-dimensional
crystals (average 1,400–3,000 particles per plaque; Fig. 4 c)
that covered 
 
z
 
90% of the apical cell surface area (Porter
and Bonneville, 1963; Hicks, 1965; Koss, 1969; Surya et al.,
1990; Walz et al., 1995; Kachar et al., 1999). In contrast, the
Figure 3. UPIII-depleted mice
had altered urothelial apical sur-
face and enlarged ureteral ori-
fices. The apical surfaces of
normal (a, c, and e) and UPIII-
depleted (b, d, and f) urothelia
(of 2–3-mo-old mice) were ex-
amined by scanning EM. Note
the highly rugged and folded
surface of large (z100–150-mm
diameter) normal umbrella cells
(arrowheads mark the outline of
one such cell in a) and the much
smaller (15–25 mm) and smooth
surfaced, UPIII-depleted super-
ficial cells. Also note the fre-
quent desquamation of the su-
perficial cells (b, *) and the
much larger ureteral orifice
(vesicoureteral junction, VJ;
120–150- vs. 40–60-mm diame-
ter) of the UPIII-depleted blad-
der. Bars: 25 mm (a and b), 5 mm
(c and d), and 50 mm (e and f). 
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apical cells of UPIII-depleted urothelium were only 15–25
 
m
 
m in diameter and were frequently seen to contract and
detach (Fig. 3, b and f), their cytoplasm lacked the mature
fusiform vesicles that were replaced by immature, smaller
discoidal vesicles (Fig. 4 b), and their apical surface was rel-
atively smooth (Figs. 3, b and d, and 4 b) with abnormally
small crystalline plaques (40–150 particles per plaque) inter-
spersed by wide, particle-free hinge areas (Fig. 4, c and d).
Fourier transformation of the small plaques of the knockout
urothelium revealed the same hexagonal symmetry and 16-
nm center-to-center distance between neighboring parti-
cles. Consistent with the decrease in the surface area cov-
ered by urothelial plaques, which have been suggested to
play a role as a permeability barrier (Chang et al., 1994), the
UPIII-depleted bladder was leaky to methylene blue (Fig.
2, e–g) (Fukui et al., 1983). The mesenchymal tissue imme-
diately underneath the urothelium was slightly more cellu-
lar with occasional inflammatory cells when compared with
the controls (Fig. 2, b and d; data not shown).
 
UPIII Ablation Led to Altered Targeting of Its
Partner UPIb
 
To localize the uroplakins, we immunohistochemically
stained the normal and UPIII-depleted mouse urothelia
using antibodies monospecific for the four uroplakins (Fig.
5). Uroplakin staining was seen in all suprabasal cell layers
of the normal urothelium (Fig. 5, left). Particularly intense
staining of the apical urothelial surface by all four uro-
plakin antibodies was evident, consistent with the fact that
 
the apical surface is highly enriched with urothelial
plaques (Fig. 5, left). The uroplakin expression pattern of
the UPIII-depleted urothelium was significantly altered
(Fig. 5, right). No UPIII could be detected (Fig. 5 d), thus
confirming the Northern and immunoblotting data (Fig. 1,
d and f). Although the UPIII-depleted urothelium showed
strong anti–keratin staining (Fig. 5 b), its staining intensity
with antibodies to uroplakins Ia, Ib, and II was in general
reduced. Interestingly, although UPIa and UPII still
showed a typical enrichment at the apical cell surface (Fig.
5, f and j; arrowheads), UPIb (the putative partner of
UPIII) showed only weak, diffuse cytoplasmic and basal-
lateral cell periphery staining, without apical enrichment
(Fig. 5 h, *). These results indicated that the elimination of
UPIII selectively affected the expression and targeting of
its presumed partner, UPIb (Wu et al., 1995).
 
Uroplakin III Deficiency and Vesicoureteral Reflux
 
Another striking feature of the UPIII-depleted mice (
 
n 
 
5
 
 5)
was that their ureteral orifices were greatly enlarged (120–
150 
 
m
 
m instead of the usual 40–60 
 
m
 
m diameter, wild-type
mice, 
 
n 
 
5
 
 4; Fig. 3, e and f). Since enlarged ureteral orifice is
thought to be an underlying feature of primary VUR (Am-
brose, 1969; Lyon et al., 1969), we instilled an Indian Ink so-
lution (via a needle) into the exposed bladders of anesthe-
tized mice and measured the hydrostatic pressure at which
urine began to back flow into the ureters (Fig. 6, a and b).
The micturition pressure (the hydrostatic pressure that in-
duced urination) of the UPIII-depleted mice was 
 
z
 
30 cm-
Figure 4. UPIII-negative urothe-
lium lacked the uroplakin-con-
taining fusiform vesicles and the
normal, apical urothelial pla-
ques. Normal (left) and UPIII-
depleted (right) mouse bladder
(of 2–3-mo-old mice) were exam-
ined by transmission electron mi-
croscopy (a and b) and by quick-
freeze/deep etch (c and d). Note
in normal urothelium the abun-
dant (uroplakin-delivering) fusi-
form cytoplasmic vesicles (a, *),
and the large plaques (a, arrows)
consisting of two-dimensional
crystals of hexagonally arranged
16-nm uroplakin protein parti-
cles (c, plaque or P), which cov-
ered almost the entire urothelial
apical surface. In contrast, note in the uroplakin III–negative urothelium the accumulation of immature, discoidal, cytoplasmic vesicles and
the absence of mature, fusiform vesicles, the relatively smooth apical surface (arrowheads) with occasional pleomorphic microvilli (d, ar-
row), and the conspicuously small urothelial plaques (P) and the wide interplaque space (hinge or H). D, L, M, and T denote desmosome,
lumen, mitochondria, and tight junction, respectively. Bars: 1,000 nm (a and b) and 200 nm (c and d). 
The Journal of Cell Biology, Volume 151, 2000 966
 
H
 
2
 
O, which was about the same as those of the two parental
mouse strains (SW and 129/SvEv) and their wild-type sib-
lings (Fig. 6 c). The reflux pressure of the parental strains as
well as the unaffected siblings was 
 
.
 
50 cm-H
 
2
 
O; this was an
under-estimation because many of the control mice could
not be induced to reflux even when the hydrostatic pressure
was raised to 
 
.
 
90 cm-H
 
2
 
O (Fig. 6 d). Some of the normal
mice refluxed briefly during urination, probably reflecting a
transient, high voiding pressure. In contrast, all the UPIII
(
 
2
 
/
 
2
 
) mice refluxed at an extremely low pressure of 14.8
 
 6
 
3.9 cm-H
 
2
 
O (
 
P 
 
5
 
 0.005; Fig. 6 d). The reflux was confirmed
by a voiding cystoureterogram (Fig. 6, e–g), a standard pro-
Figure 5. Altered expression of uroplakins in the UPIII-depleted
urothelium. Paraffin-sections of normal (left) and uroplakin III–
depleted (2–3-mo-old) mouse urothelia (right) were deparaf-
finized and stained immunohistochemically using antibodies to
keratins (AE1 plus AE3) (a and b), uroplakin III (c and d),
uroplakin Ia (e and f), uroplakin Ib (g and h), and uroplakin II (i
and j). Note the concentration of all four uroplakins on the apical
surface of normal urothelium (arrowheads); in contrast, only UPIa
and UPII are apical-concentrated in the UPIII-depleted urothe-
lium. (h, arrows) The association of UPIb with lateral cell surface,
instead of apical surface (*) of the UPIII-depleted urothelium. L,
bladder lumen. Bars: 25 mm (a and b) and 50 mm (c–j).
Figure 6. UPIII-depleted mice had vesicoureteral reflux (VUR).
(a–b) An Indian Ink assay. Instillation of a 0.1% Indian Ink solution
into the bladders of the UPIII-depleted mice (2–3-mo old) at hydro-
static pressures of 10 (a) and 26 (b) mm-H2O. This animal had reflux
and micturition pressures of 15 and 28.5 cm-H2O, respectively. Note
the retrograde flow of the black fluid into the ureters in b. (c) The
micturition pressure was measured for the two parent mouse strains;
i.e., SW (n 5 10) and 129/SvEv (n 5 7), as well as the UPIII-knock-
out (KO) mice (n 5 5) and their wild-type (WT) siblings (n 5 5).
Note that all four mouse strains had about the same micturition
pressure (MP) of 25–30 cm-H2O. (d) The vesicoureteral reflux pres-
sure (RP) of the same four mouse lines. Note the occurrence of vesi-
coureteral reflux in the UPIII-depleted mice at z15 cm-H2O, which
was significantly lower than the other three control strains (.55 cm;
P 5 0.005). Brackets indicate SD. *The RP of animals that did not
reflux at 90 cm-H2O were arbitrarily taken as 90; thus the RP of SW,
WT, and 129 were greatly underestimated. (e and f) Voiding cys-
toureterogram of normal animal showing no reflux (e) and of a
UPIII-KO mouse showing reflux into the kidneys (f and g). B, blad-
der; K, kidney; and U, ureter. Bars: 5 mm (a and b).Hu et al. Uroplakin Ablation and Vesicoureteral Reflux 967
cedure for diagnosing VUR in humans. These results
clearly established that our UPIII-depleted mice had abnor-
mal ureteral orifices and VUR.
Hydronephrosis and Altered Renal Function Indicators
Since it is known that reflux can sometimes lead to renal
damage and nephropathy, we assessed the renal structure
and function of the UPIII-depleted mice. The renal pelvis
of many such mice was enlarged (n 5 12 of 20 F1 UPIII-
deficient animals; Fig. 7, a and b), with significantly dilated
collecting ducts and distal tubules (e and f), but minimally
perturbed renal cortex (c and d). To assess the micturition
pattern, we housed the mice singly in (fine) wire-floored
cages underlined with a filter paper that was changed at
regular intervals, so that the urine volume could be mea-
sured based on the surface areas covered by the fluores-
cent urine (Fig. 8 a). We found that while the average vol-
ume per micturition of the UPIII-depleted mice was
within the normal range (Fig. 8 b), the UPIII-depleted
mice urinated almost twice as frequently as the controls
(P 5 0.009; Fig. 8 c), resulting in a doubling of the total urine
output per day (P 5 0.008; Fig. 8 d). Moreover, unlike the
normal urine that had a pH value of 5–7 (n 5 30), the uri-
nary pH of z15% of the knockout mice (n 5 45) was $8.
Finally, the levels of serum creatinine and blood urea ni-
trogen of the UPIII-depleted mice were 1.36 (P 5 0.05)
and 1.4 (P 5 0.01) times higher than those of the control
animals (Fig. 8, e and f). Similar results were obtained with
male and female animals (Fig. 8, b–d). These results indi-
cated that some of the indicators of renal function, includ-
ing filtration, concentration, and urine acidification, had
been affected. Although these changes could reflect renal
damage or dysfunction, it is also possible that they simply
reflect the reabsorption of some of the urine components
through a leaky urothelium. 
Discussion
Using the gene-targeting approach, we show here that
uroplakin III plays an indispensable role in forming normal
urothelial plaques, that UPIII pairs with UPIb, that UPIII
deficiency perturbs important urothelial functions, and that
this deficiency can lead to VUR and associated anomalies
affecting the entire urinary system, including the kidneys.
Uroplakin III Deficiency Causes Major
Urothelial Anomalies
Numerous examples exist in which mutations in a tissue-
specific differentiation product lead to organ-restricted
abnormalities. We therefore sought to determine whether
defects in uroplakins, the major differentiation products
of urothelium, would cause urothelial-specific problems.
Two issues were of concern, however, in taking this ap-
proach. First, although urothelial research has been tradi-
Figure 7. UPIII-ablation in-
duced hydronephrosis and kid-
ney abnormalities. Paraffin sec-
tions (hematoxylin and eosin
stained) of kidneys of normal (a,
c, and e) and UPIII-depleted (b,
d, and f) mice (2–3-mo old). (a
and b) Low magnification view,
(c and d) cortex, and (e and f)
papilla. Note the expanded re-
nal pelvic space and the dilation
of the collecting ducts in the
UPIII-depleted mice. C, cortex;
MD, medulla; P,  papilla; and
RP, renal pelvis. Bar: 1 mm (a
and b) and 50 mm (e and f).The Journal of Cell Biology, Volume 151, 2000 968
tionally focused on the bladder, no known congenital blad-
der disease other than exstrophy (Shapiro et al., 1984)
exists in the literature. Second, sequence analysis indicates
that the four uroplakins can be divided into two structur-
ally related groups. Thus, UPIa and UPIb are closely re-
lated, sharing z30% of their amino acid sequence, and
both belong to a family of proteins, called tetraspanins,
having four transmembrane domains (TMD) (Yu et al.,
1994). On the other hand, UPII and UPIII have only one
TMD, and they share a stretch of z12 amino acids that are
adjacent to the TMD on the NH2-terminal, luminal side
(Wu and Sun, 1993; Lin et al., 1994). It is possible, there-
fore, that the structurally related UPII and UPIII (or UPIa
and Ib) can substitute for its defective “analogue,” result-
ing in no phenotype. Such a functional redundancy could
explain why no congenital bladder disease seems to exist.
Our data clearly demonstrate, however, that UPIII can-
not be substituted by its structurally related UPII (Figs.
2–8). This is perhaps not surprising, given the limited struc-
tural similarity between these two proteins and the fact that
UPIII has several unique features. First, UPIII is the only
uroplakin possessing a significant cytoplasmic domain (of
z50 amino acids) that may play a role in anchoring the
urothelial plaques onto an underlying cytoskeleton (Stae-
helin et al., 1972; Wu and Sun, 1993). Second, while UPIa
and UPIb harbor only 1–2-kD equivalents of high mannose
sugars and the mature UPII harbors no sugars, uroplakin
III harbors almost 20-kD equivalents of complex sugars
(Wu and Sun, 1993). UPIII may therefore contribute to
most of the sugar components present on the apical surface
of urothelial plaques. Third, chemical cross-linking studies
have shown that uroplakins III and II bind preferentially to
uroplakins Ib and Ia, respectively (Wu et al., 1995). Despite
the structural similarities between UPIa and Ib, we show
here that UPIII deletion selectively affects UPIb expres-
sion and maturation (Figs. 1 and 5). This, plus the specific
interaction of UPIa and Ib with UPII and III, respectively,
strongly suggests that even the structurally closely related
UPIa and Ib are functionally distinct in vivo.
We have thus provided the first animal model of congenital
urinary tract anomalies due to urothelial defects, in this case
caused by the deletion of uroplakin III gene. In addition, the
fact that uroplakins may not be functionally redundant
greatly increases the likelihood that mutations in UPIII and
other uroplakins can cause urothelial defects resulting in ex-
tensive abnormalities in the entire urinary tract—a concept
that can have major clinical implications (see below).
Roles of UPIII and Uroplakin Pairs in Urothelial 
Plaque Formation
Based on the fact that uroplakins are the main protein
components found in highly purified mammalian urothe-
lial plaques, and also based on immunogold localization
data, we suggested previously that uroplakins are the ma-
jor building blocks of urothelial plaques (Wu et al., 1990;
Yu et al., 1990). Furthermore, as mentioned, cross-linking
studies suggested the existence of two uroplakin pairs (Wu
et al., 1995). Our present data confirm and extend these
observations. (a) Knockout of UPIII results in a grossly re-
duced number of apical urothelial plaques (Fig. 4), thus
providing unequivocal proof that UPIII is an integral sub-
unit of the plaques. (b) At the messenger RNA level, al-
though UPIII-knockout does not significantly alter the
level of uroplakins Ia and II mRNA’s (approximately two-
fold), it induces an approximately fivefold increase in
UPIb message, possibly due to a feedback regulation (Fig.
1 d). (c) At the protein level, UPIII deletion does not ap-
preciably alter the amounts of UPIa and UPII (Fig. 1 f);
however, this hampers UPIb maturation, suggesting that
specific interactions between UPIb and III, presumably oc-
curring in the rough endoplasmic reticulum, play a crucial
role in UPIb maturation (Fig. 1 f) (Wu et al., 1995). (d) Im-
munohistochemical staining of the UPIII-negative urothe-
lium shows that only uroplakins Ia and II are concentrated
on the apical urothelial surface, while (the partnerless)
UPIb is distributed diffusely in the cytoplasm and in the
basal/lateral cell periphery (Fig. 5). (e) Only small patches
of the urothelial plaque remain on the apical surface of the
UPIII-negative urothelium (Fig. 4 d); such small patches
have structural parameters similar to the normal plaques
and are likely to consist of the Ia/II uroplakins.
Taken together, these data indicate that deletion of
UPIII leads to the abnormal maturation of its partner
UPIb (Figs. 1 and 5), thus providing strong support to the
concept that the four known uroplakins form two pairs
consisting of uroplakins Ia/II and Ib/III (Figs. 1 and 5), and
that the remaining Ia/II pair can only form abnormally
small patches of urothelial plaques (Fig. 4). These results
provide unambiguous evidence that UPIII is an integral
and indispensable subunit of urothelial plaques, which are
Figure 8. Renal function of
the UPIII-depleted mice.
The micturition pattern of
UPIII-depleted mice (13
males and 11 females, all
2–3-mo old) and an equal
number of their wild-type sib-
lings were determined by
measuring the surface area of
a filter paper that was cov-
ered by the fluorescent urine
(see Materials and Methods);
the paper was changed every
15 min during a period of
24 h. (a) The standard curve
showing the correlation be-
tween the mouse urine vol-
ume and the surface area
covered by the fluorescent
urine. (b) Average volume
(V;  ml) of urine per micturi-
tion. (c) Number of micturi-
tion (times). (d) The cumula-
tive urine volume. For blood
analysis, sera from 10 UPIII-
depleted and 10 wild-type
sibling mice were pooled. (e)
Blood urea nitrogen (BUN)
concentration of the wild-type
and UPIII-knockout mice.
(f) Serum creatinine (SC)
concentration of the wild-
type and knockout mice.Hu et al. Uroplakin Ablation and Vesicoureteral Reflux 969
required for maintaining a normal-looking and function-
ally competent urothelium (Figs. 2–4). Further analysis of
the UPIII-depleted mice should provide excellent oppor-
tunities to define more precisely the functional role of
urothelial plaques in establishing the permeability barrier
and other properties of the urothelium. Results from such
analyses can also have implications for certain bladder dis-
eases, such as interstitial cystitis.
Functional Roles of Urothelial Plaques
As the major specialization product of mammalian urothe-
lia, the apical surface plaques are thought to perform three
possible functions that are not necessarily mutually exclu-
sive, including physical stabilization, surface area adjust-
ment, and permeability barrier. Although the plaques of
the UPIII-depleted urothelium are unusually small and
widely dispersed (Fig. 4 d), careful histological examina-
tion of the urothelia from .20 adult animals revealed no
evidence of urothelial rupture. In addition, the average
micturition volume of the UPIII-depleted mice is normal,
indicating that if the smaller plaques have hampered the
reversible adjustment of urothelial surface area, such a de-
fect has not resulted in a significantly diminished bladder
capacity (Fig. 8 b). Interestingly, although normal urothe-
lium is impermeable to methylene blue, this dye readily
penetrates the UPIII-depleted urothelium (Fig. 2, e–g)
and is taken up by the nuclei, suggesting that the dye has
entered the urothelial cell via its apical surface. A compro-
mised permeability barrier function may explain some of
the phenotypes of the UPIII-depleted mice. It is known
that if, during development, Wolffian duct budding occurs
too close to the future bladder, this can lead to the dis-
placement of the vesicoureteral junction to a more lateral
region of the bladder, resulting in a shortened intravesical
ureteral tunnel with an enlarged orifice (Atala and Keat-
ing, 1998; Pope et al., 1999). It is possible that the defective
urothelium somehow perturbs this budding process, re-
sulting in enlarged ureteral orifices and the subsequent
vesicoureteral reflux, hydronephrosis, and altered renal
function. Overall, although one cannot exclude the roles
of stabilization and surface area adjustment, our data
strongly support the idea that urothelial plaques contrib-
ute to the permeability barrier function (Hicks, 1975;
Chang et al., 1994). Additional studies are underway to
better define the electric resistance and permeability pa-
rameters of the UPIII-depleted urothelium.
Interstitial cystitis, the “painful bladder syndrome” affect-
ing mainly women, is characterized by pelvic and/or perineal
pain, urinary urgency, and frequency (Sant and Theoharides,
1999). It has been suggested that defects in the urothelial per-
meability barrier may allow some urine components to leak
into the underlying mesenchymal tissues, causing irritation
and inflammation, which, in turn, lead to some of the above
symptoms. It is interesting to note that the UPIII-depleted
mice have a rather normal urine volume per micturition (Fig.
8 b), suggesting that urothelial leakage (Fig. 2, e–g) may not
necessarily lead to irritation-related urinary urgency, as indi-
cated by a reduced volume per micturition.
Urothelial Defects May Cause a Subgroup of
Human VUR
Although VUR is thought to facilitate urinary tract infec-
tion, it has also been suggested that it is infection, with the
release of bacterial endotoxins, that inhibits ureteral peri-
stalsis, thus causing vesicoureteral reflux (Roberts, 1992;
Garin et al., 1998). However, our experiments clearly
demonstrate that VUR can occur as a primary event. This
interpretation is consistent with the clinical finding that al-
though 38% of pediatric patients with urinary tract infec-
tion have vesicoureteral reflux, a remarkable 48% of the
asymptomatic siblings of these patients were also found to
have reflux (Peeden and Noe, 1992).
Conflicting data exist regarding the hereditary basis of
VUR. Thus, it has been proposed that VUR involves the
dominant negative mutations of a single gene (Bailey et
al., 1984; Chapman et al., 1985), but it has also been said
that VUR is polygenic and heterogeneous with incomplete
penetrance (de Vargas et al., 1978; Nishimura et al., 1999;
Feather et al., 2000). Moreover, since VUR is sometimes
associated with other congenital uropathies and nephropa-
thies including ureteral duplication, vesicoureteral junc-
tion obstruction, ureteropelvic junction obstruction, and
renal aplasia, hypoplasia and dysplasia, it has been sug-
gested that VUR and some of these other urological and
renal malformations share common mutations (Atwell,
1985; Becker and Avner, 1995; Devriendt et al., 1998;
Pope et al., 1999). In this regard, it is interesting that the
deletion of the angiotensin type 2 receptor gene (AGTR2)
can also cause VUR. However, the VUR of the AGTR2-
and UPIII-depleted mice seems to be different. Thus, the
AGTR2 deletion-induced VUR affects only a small per-
centage of male mice with low penetrance and is associ-
ated with other forms of congenital anomalies of the kid-
ney and urinary tract (CAKUT) (Nishimura et al., 1999).
On the other hand, the UPIII depletion-induced VUR af-
fects both sexes equally with high penetrance and it occurs
in the absence of other forms of CAKUT. These results
strongly suggest that there are at least two subtypes of
VUR with distinct genetic bases.
We have shown here that the ablation of uroplakin III
gene can cause VUR, and it will be of major interest to see
whether defects in several other urothelial-specific genes
will yield similar or related phenotypes. Like UPIII, these
genes are expressed as terminal differentiation markers
and are associated with the umbrella cells; they include
uroplakins Ia, Ib, and II (Wu and Sun, 1993; Lin et al.,
1994; Yu et al., 1994; Sun et al., 1999), and an 85-kD uro-
hingin (Yu et al., 1992). The urothelium specificity of these
genes makes them good candidate genes that can cause
multiple anomalies within the urinary tract. That some of
these genes may be involved in human VUR is suggested
by a recent report that mapped VUR genes to multiple
chromosomal sites, including two that coincide with the lo-
cation of genes encoding uroplakin III (chromosome 22,
40-44 cM) and uroplakin Ib (chromosome 3, 117-184 cM)
(Finch et al., 1997; Feather et al., 2000). Additional studies
are needed to determine whether defects in such genes are
indeed involved in subpopulation of human VUR.
Concluding Remarks
Studies on the uroplakin III–knockout mice that we de-
scribe here have shed light on the structure and function of
urothelial plaques and on the possible molecular bases of
VUR. Our results also raise several important questions.
How are the uroplakins targeted and assembled at the
urothelial apical surface? What is the role of the geneticThe Journal of Cell Biology, Volume 151, 2000 970
background in affecting the severity of the disease pheno-
type? What are the developmental pathways of VUR for-
mation? What is the role of nontrauma-induced reflux in
the pyelonephritis that occurs frequently in reflux pa-
tients? Finally, will the compromised urothelial permeabil-
ity barrier function, coupled with other factors, lead to a
hyperactive or hypersensitive bladder, and/or enhanced
bladder tumorigenesis? Additional studies on mouse
model systems, such as the one described here, should al-
low us to address these important issues.
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